Molecular Mechanisms Associated with ROS-Dependent Angiogenesis in Lower Extremity Artery Disease

Currently, atherosclerosis, which affects the vascular bed of all vital organs and tissues, is considered as a leading cause of death. Most commonly, atherosclerosis involves coronary and peripheral arteries, which results in acute (e.g., myocardial infarction, lower extremities ischemia) or chronic...

Full description

Bibliographic Details
Main Authors: Greg Hutchings, Łukasz Kruszyna, Mariusz J. Nawrocki, Ewa Strauss, Rut Bryl, Julia Spaczyńska, Bartłomiej Perek, Marek Jemielity, Paul Mozdziak, Bartosz Kempisty, Michał Nowicki, Zbigniew Krasiński
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/10/5/735
_version_ 1827693201003118592
author Greg Hutchings
Łukasz Kruszyna
Mariusz J. Nawrocki
Ewa Strauss
Rut Bryl
Julia Spaczyńska
Bartłomiej Perek
Marek Jemielity
Paul Mozdziak
Bartosz Kempisty
Michał Nowicki
Zbigniew Krasiński
author_facet Greg Hutchings
Łukasz Kruszyna
Mariusz J. Nawrocki
Ewa Strauss
Rut Bryl
Julia Spaczyńska
Bartłomiej Perek
Marek Jemielity
Paul Mozdziak
Bartosz Kempisty
Michał Nowicki
Zbigniew Krasiński
author_sort Greg Hutchings
collection DOAJ
description Currently, atherosclerosis, which affects the vascular bed of all vital organs and tissues, is considered as a leading cause of death. Most commonly, atherosclerosis involves coronary and peripheral arteries, which results in acute (e.g., myocardial infarction, lower extremities ischemia) or chronic (persistent ischemia leading to severe heart failure) consequences. All of them have a marked unfavorable impact on the quality of life and are associated with increased mortality and morbidity in human populations. Lower extremity artery disease (LEAD, also defined as peripheral artery disease, PAD) refers to atherosclerotic occlusive disease of the lower extremities, where partial or complete obstruction of peripheral arteries is observed. Decreased perfusion can result in ischemic pain, non-healing wounds, and ischemic ulcers, and significantly reduce the quality of life. However, the progressive atherosclerotic changes cause stimulation of tissue response processes, like vessel wall remodeling and neovascularization. These mechanisms of adapting the vascular network to pathological conditions seem to play a key role in reducing the impact of the changes limiting the flow of blood. Neovascularization as a response to ischemia induces sprouting and expansion of the endothelium to repair and grow the vessels of the circulatory system. Neovascularization consists of three different biological processes: vasculogenesis, angiogenesis, and arteriogenesis. Both molecular and environmental factors that may affect the process of development and growth of blood vessels were analyzed. Particular attention was paid to the changes taking place during LEAD. It is important to consider the molecular mechanisms underpinning vessel growth. These mechanisms will also be examined in the context of diseases commonly affecting blood vessel function, or those treatable in part by manipulation of angiogenesis. Furthermore, it may be possible to induce the process of blood vessel development and growth to treat peripheral vascular disease and wound healing. Reactive oxygen species (ROS) play an important role in regulation of essential cellular signaling pathways such as cell differentiation, proliferation, migration and apoptosis. With regard to the repair processes taking place during diseases such as LEAD, prospective therapeutic methods have been described that could significantly improve the treatment of vessel diseases in the future. Summarizing, regenerative medicine holds the potential to transform the therapeutic methods in heart and vessel diseases treatment.
first_indexed 2024-03-10T11:39:16Z
format Article
id doaj.art-5985b5fe8ffe4282acbdf42bc907894a
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T11:39:16Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-5985b5fe8ffe4282acbdf42bc907894a2023-11-21T18:37:39ZengMDPI AGAntioxidants2076-39212021-05-0110573510.3390/antiox10050735Molecular Mechanisms Associated with ROS-Dependent Angiogenesis in Lower Extremity Artery DiseaseGreg Hutchings0Łukasz Kruszyna1Mariusz J. Nawrocki2Ewa Strauss3Rut Bryl4Julia Spaczyńska5Bartłomiej Perek6Marek Jemielity7Paul Mozdziak8Bartosz Kempisty9Michał Nowicki10Zbigniew Krasiński11The School of Medicine, Medical Sciences and Nutrition, Aberdeen University, Aberdeen AB25 2ZD, UKDepartment of Vascular and Endovascular Surgery, Angiology and Phlebology, Poznan University of Medical Sciences, 60-848 Poznan, PolandDepartment of Anatomy, Poznan University of Medical Sciences, 60-781 Poznan, PolandDepartment of Vascular and Endovascular Surgery, Angiology and Phlebology, Poznan University of Medical Sciences, 60-848 Poznan, PolandDepartment of Anatomy, Poznan University of Medical Sciences, 60-781 Poznan, PolandDepartment of Anatomy, Poznan University of Medical Sciences, 60-781 Poznan, PolandDepartment of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, 61-848 Poznan, PolandDepartment of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, 61-848 Poznan, PolandPhysiology Graduate Program, North Carolina State University, Raleigh, NC 27695, USADepartment of Anatomy, Poznan University of Medical Sciences, 60-781 Poznan, PolandPrestage Department of Poultry Science, North Carolina State University, Raleigh, NC 27695, USADepartment of Vascular and Endovascular Surgery, Angiology and Phlebology, Poznan University of Medical Sciences, 60-848 Poznan, PolandCurrently, atherosclerosis, which affects the vascular bed of all vital organs and tissues, is considered as a leading cause of death. Most commonly, atherosclerosis involves coronary and peripheral arteries, which results in acute (e.g., myocardial infarction, lower extremities ischemia) or chronic (persistent ischemia leading to severe heart failure) consequences. All of them have a marked unfavorable impact on the quality of life and are associated with increased mortality and morbidity in human populations. Lower extremity artery disease (LEAD, also defined as peripheral artery disease, PAD) refers to atherosclerotic occlusive disease of the lower extremities, where partial or complete obstruction of peripheral arteries is observed. Decreased perfusion can result in ischemic pain, non-healing wounds, and ischemic ulcers, and significantly reduce the quality of life. However, the progressive atherosclerotic changes cause stimulation of tissue response processes, like vessel wall remodeling and neovascularization. These mechanisms of adapting the vascular network to pathological conditions seem to play a key role in reducing the impact of the changes limiting the flow of blood. Neovascularization as a response to ischemia induces sprouting and expansion of the endothelium to repair and grow the vessels of the circulatory system. Neovascularization consists of three different biological processes: vasculogenesis, angiogenesis, and arteriogenesis. Both molecular and environmental factors that may affect the process of development and growth of blood vessels were analyzed. Particular attention was paid to the changes taking place during LEAD. It is important to consider the molecular mechanisms underpinning vessel growth. These mechanisms will also be examined in the context of diseases commonly affecting blood vessel function, or those treatable in part by manipulation of angiogenesis. Furthermore, it may be possible to induce the process of blood vessel development and growth to treat peripheral vascular disease and wound healing. Reactive oxygen species (ROS) play an important role in regulation of essential cellular signaling pathways such as cell differentiation, proliferation, migration and apoptosis. With regard to the repair processes taking place during diseases such as LEAD, prospective therapeutic methods have been described that could significantly improve the treatment of vessel diseases in the future. Summarizing, regenerative medicine holds the potential to transform the therapeutic methods in heart and vessel diseases treatment.https://www.mdpi.com/2076-3921/10/5/735peripheral arterial diseasesangiogenesisneovascularizationatherosclerosis
spellingShingle Greg Hutchings
Łukasz Kruszyna
Mariusz J. Nawrocki
Ewa Strauss
Rut Bryl
Julia Spaczyńska
Bartłomiej Perek
Marek Jemielity
Paul Mozdziak
Bartosz Kempisty
Michał Nowicki
Zbigniew Krasiński
Molecular Mechanisms Associated with ROS-Dependent Angiogenesis in Lower Extremity Artery Disease
Antioxidants
peripheral arterial diseases
angiogenesis
neovascularization
atherosclerosis
title Molecular Mechanisms Associated with ROS-Dependent Angiogenesis in Lower Extremity Artery Disease
title_full Molecular Mechanisms Associated with ROS-Dependent Angiogenesis in Lower Extremity Artery Disease
title_fullStr Molecular Mechanisms Associated with ROS-Dependent Angiogenesis in Lower Extremity Artery Disease
title_full_unstemmed Molecular Mechanisms Associated with ROS-Dependent Angiogenesis in Lower Extremity Artery Disease
title_short Molecular Mechanisms Associated with ROS-Dependent Angiogenesis in Lower Extremity Artery Disease
title_sort molecular mechanisms associated with ros dependent angiogenesis in lower extremity artery disease
topic peripheral arterial diseases
angiogenesis
neovascularization
atherosclerosis
url https://www.mdpi.com/2076-3921/10/5/735
work_keys_str_mv AT greghutchings molecularmechanismsassociatedwithrosdependentangiogenesisinlowerextremityarterydisease
AT łukaszkruszyna molecularmechanismsassociatedwithrosdependentangiogenesisinlowerextremityarterydisease
AT mariuszjnawrocki molecularmechanismsassociatedwithrosdependentangiogenesisinlowerextremityarterydisease
AT ewastrauss molecularmechanismsassociatedwithrosdependentangiogenesisinlowerextremityarterydisease
AT rutbryl molecularmechanismsassociatedwithrosdependentangiogenesisinlowerextremityarterydisease
AT juliaspaczynska molecularmechanismsassociatedwithrosdependentangiogenesisinlowerextremityarterydisease
AT bartłomiejperek molecularmechanismsassociatedwithrosdependentangiogenesisinlowerextremityarterydisease
AT marekjemielity molecularmechanismsassociatedwithrosdependentangiogenesisinlowerextremityarterydisease
AT paulmozdziak molecularmechanismsassociatedwithrosdependentangiogenesisinlowerextremityarterydisease
AT bartoszkempisty molecularmechanismsassociatedwithrosdependentangiogenesisinlowerextremityarterydisease
AT michałnowicki molecularmechanismsassociatedwithrosdependentangiogenesisinlowerextremityarterydisease
AT zbigniewkrasinski molecularmechanismsassociatedwithrosdependentangiogenesisinlowerextremityarterydisease